论文部分内容阅读
原发性肝细胞肝癌(以下简称“肝癌”)是世界第五大肿瘤,但其死亡率居肿瘤导致死亡的第2位。肝癌起病隐匿,恶性程度高,早期无特异性症状。大多数肝癌病人就诊时已进入晚期。因此,寻找准确、有效的肝癌分子标志物对提高肝癌病人生存率有重要意义。甲胎蛋白(alpha fetal protein,AFP)是目前应用较广泛的肝癌诊断分子标志物,然而其
Primary hepatocellular carcinoma (hereinafter referred to as “hepatocellular carcinoma”) is the fifth largest tumor in the world, but its death rate ranks second in the tumor-causing death. Liver cancer occult onset, high degree of malignancy, early non-specific symptoms. Most of the liver cancer patients have entered advanced stages of treatment. Therefore, to find accurate and effective molecular markers of liver cancer to improve the survival rate of patients with liver cancer is of great significance. Alpha-fetoprotein (AFP) is the most widely used diagnostic molecular marker of liver cancer, however, its